Detail (Long)
Lateral vertebral fx assessment on DEXA equipment or lateral T + L-spine x-ray indicated if:<br>
◦ <b>NOF:</b><sup>9</sup> ≥50 yo and postmenopausal w/ the following risk factors: fx during adulthood (any cause); historical ht loss ≥1.5" (peak ht – current ht); prospective ht loss ≥0.8" (last documented ht − current ht); recurrent or ongoing long-term GC tx (≥5 mg prednisone or equivalent daily for ≥3mo<sup>6</sup>); hyperparathyroidism<br>
◦ <b>ISCD:</b><sup>12</sup> BMD T-score <−1 + at least one of the following: historical ht loss >4 cm (>1.5"); self-reported but undocumented prior vertebral fx; GC tx equivalent to ≥5 mg prednisone daily for ≥3mo<br>
◦ <b>AACE:</b><sup>3</sup> unexplained ht loss, self-reported but undocumented prior spine fx, GC tx equivalent to ≥5 mg prednisone daily for ≥3mo<br>
◦ <b>NOF:</b><sup>9</sup> ≥50 yo and postmenopausal w/ the following risk factors: fx during adulthood (any cause); historical ht loss ≥1.5" (peak ht – current ht); prospective ht loss ≥0.8" (last documented ht − current ht); recurrent or ongoing long-term GC tx (≥5 mg prednisone or equivalent daily for ≥3mo<sup>6</sup>); hyperparathyroidism<br>
◦ <b>ISCD:</b><sup>12</sup> BMD T-score <−1 + at least one of the following: historical ht loss >4 cm (>1.5"); self-reported but undocumented prior vertebral fx; GC tx equivalent to ≥5 mg prednisone daily for ≥3mo<br>
◦ <b>AACE:</b><sup>3</sup> unexplained ht loss, self-reported but undocumented prior spine fx, GC tx equivalent to ≥5 mg prednisone daily for ≥3mo<br>